The progression of congestive heart failure over the course of the sudden cardiac death in heart failure trial (SCD-HeFT)

Gust H Bardy,Kerry L Lee,John P Boehmer,Daniel B Mark,Jeanne E Poole,Daniel P Fisbein,Anne S Hellkamp,Steven E Mcnulty,Jill Anderson,George W Johnson,Robin Boineau,Michael J Domanski

doi:10.1016/j.hrthm.2005.02.130

The progression of congestive heart failure over the course of the sudden cardiac death in heart failure trial (SCD-HeFT)

Gust H Bardy, Kerry L Lee + Show 10 more

https://doi.org/10.1016/j.hrthm.2005.02.130

Copy DOI

Journal: Heart rhythm	Publication Date: May 1, 2005
Citations: 7

Affiliation: The Seattle Institute for Cardiac Research

#Sudden Cardiac Death In Heart Failure Trial #Death In Heart Failure Trial + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Introduction: In SCD-HeFT, single-lead, shock-only ICDs improved survival by 23% with benefit more pronounced in Class II pts. Background CHF drug therapy was good. At last follow-up (median 45.5mo), 87% were on ACE Inhibitors and/or angiotensin receptor blockers and 78% were on beta-blockers.

Full Text